Abciximab Bolus Injection Does Not Reduce Cerebral Ischemic Complications of Elective Carotid Artery Stenting | Zendy

Robert Hofmann | Zendy; Klaus Kerschner | Zendy; Clemens Steinwender | Zendy; Alexander Kypta | Zendy; Dietmar Bibl | Zendy; F Leisch | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Abciximab Bolus Injection Does Not Reduce Cerebral Ischemic Complications of Elective Carotid Artery Stenting

Author(s) -

Robert Hofmann,

Klaus Kerschner,

Clemens Steinwender,

Alexander Kypta,

Dietmar Bibl,

F Leisch

Publication year - 2002

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/hs0302.104545

Subject(s) - medicine , abciximab , carotid stenting , aspirin , clopidogrel , anesthesia , stroke (engine) , cardiology , surgery , carotid endarterectomy , myocardial infarction , carotid arteries , percutaneous coronary intervention , mechanical engineering , engineering

Abciximab has been shown to significantly reduce thromboembolic complications of coronary artery stenting. A prospective, randomized study was performed to test whether abciximab has comparable beneficial effects in carotid artery stenting.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research